Monkey Pox Testing Market Report 2026

Monkey Pox Testing Market Overview

• Monkey Pox Testing market size has reached to $1.52 billion in 2025 • Expected to grow to $1.88 billion in 2030 at a compound annual growth rate (CAGR) of 4.3% • Growth Driver: Increasing Incidence Of Monkey Pox Disease Is Driving The Growth Of The Monkey Pox Testing Market. • Market Trend: Innovations In Lyophilised RT-PCR Technology Enhance Accessibility And Diagnostic Accuracy In Monkeypox Testing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Monkey Pox Testing Market?

Monkeypox testing refers to the diagnostic process used to detect the presence of the monkeypox virus in an individual. This testing is crucial for identifying and confirming cases of monkeypox, a viral zoonotic disease that can be transmitted from animals to humans and between humans. The main technologies for money pox testing are polymerase chain reaction (PCR), lateral flow assay (LFA), and others. Polymerase Chain Reaction (PCR) is a molecular technique used to amplify and detect the DNA of the monkeypox virus in patient samples, making it a key tool for accurate and early diagnosis of the disease. It enables rapid identification of viral genetic material, crucial for controlling outbreaks. Testing modes include laboratory testing and point-of-care testing, with end users such as hospitals and clinics, diagnostic laboratories, and others.

What Is The Monkey Pox Testing Market Growth Forecast?

The monkey pox testing market size is expected to see steady growth in the next few years. It will grow to $1.88 billion in 2030 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to expansion of molecular testing capacity, increasing adoption of point-of-care diagnostics, rising government surveillance initiatives, growth in research funding, development of rapid antigen technologies. Major trends in the forecast period include expansion of advanced molecular diagnostic platforms, adoption of AI-based outbreak prediction and case mapping, growth in iot-enabled remote testing infrastructure, development of high-throughput automated testing systems, increasing integration of cloud-based laboratory data networks.

Global Monkey Pox Testing Market Segmentation

1) By Technology: Polymerase Chain Reaction (PCR), Lateral Flow Assay (LFA), Other Technologies 2) By Mode: Laboratory Testing, Point Of Care Testing 3) By End-Use: Hospitals And Clinics, Diagnostic Laboratories, Other End-Uses Subsegments: 1) By Polymerase Chain Reaction (PCR): Real-Time PCR (qPCR), Reverse Transcription PCR (RT-PCR), Multiplex PCR 2) By Lateral Flow Assay (LFA): Immunochromatographic Lateral Flow Assays, Rapid Antigen Detection Kits 3) By Other Technologies: Enzyme-Linked Immunosorbent Assay (ELISA), CRISPR-Based Testing, Serological Tests (Antibody Detection)

What Is The Driver Of The Monkey Pox Testing Market?

The increasing incidence of monkey pox disease is expected to propel the growth of the monkey pox testing market going forward. Monkeypox is a rare viral disease caused by the monkeypox virus, a member of the orthodox virus genus related to the smallpox virus. The rise in monkeypox cases is due to increased human-to-human transmission, global travel, and reduced immunity from discontinued smallpox vaccination programs. Monkeypox testing helps by identifying infected individuals early, allowing for timely treatment and isolation to prevent further spread of the disease. It also aids in tracking outbreaks and understanding the virus's transmission patterns. For instance, in September 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, From 14 August 2023 to 11 September 2023, the 1,131 new confirmed cases of mpox, along with five additional related deaths. Therefore, the increasing incidence of monkey pox disease is driving the growth of the monkey pox testing industry.

Key Players In The Global Monkey Pox Testing Market

Major companies operating in the monkey pox testing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Mayo Clinic Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sonic Healthcare Limited, bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Cepheid Inc., Aegis Sciences Corporation, Chembio Diagnostics Inc., Flow Health Inc., SeraCare Life Sciences Inc., BioGX Inc., Applied DNA Sciences Inc., CerTest Biotec S.L., Altona Diagnostics GmbH, Creative Biogene Inc., ACON Biotech (Hangzhou) Co Ltd.

Global Monkey Pox Testing Market Trends and Insights

Major companies operating in the monkey pox testing market are focusing on developing advanced solutions such as lyophilised component RT PCR kits to enhance diagnostic accessibility and reliability. Lyophilised component technology involves freeze drying the reagents so they remain stable at ambient temperatures and can be shipped without cold chain logistics. This reduces dependency on cold storage and enables deployment in remote areas while maintaining test accuracy and reliability. For instance, in August 2024, Andhra Pradesh MedTech Zone (AMTZ), an India based facility, in partnership with Transasia Diagnostics, launched the ErbaMDx Monkeypox RT-PCR Kit featuring lyophilised reagents and receiving validation from Indian Council for Medical Research (ICMR) and emergency authorization from Central Drugs Standard Control Organisation (CDSCO). The kit offers a 12 month shelf life and zero cross reactivity with other orthopoxviruses enabling highly specific detection. It allows storage and transport at ambient temperature making it suitable for remote and resource limited settings. The kit helps strengthen India’s epidemic preparedness by offering precise, reliable and accessible mpox diagnosis even in areas without cold chain infrastructure.

What Are Latest Mergers And Acquisitions In The Monkey Pox Testing Market?

In September 2023, BioNTech, a UK-based biotechnology company, has partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) for an undisclosed amount. This partnership seeks to speed up the development of effective vaccines for mpox (formerly known as monkeypox), a disease that has attracted increased attention due to recent outbreaks. The Coalition for Epidemic Preparedness Innovations (CEPI) is a UK-based public-private organization focused on vaccine development.

Regional Outlook

North America was the largest region in the monkey pox testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Monkey Pox Testing Market?

The monkey pox testing market consist of revenues earned by entities by providing services such as laboratory testing, diagnostic consultation, sample collection, result reporting, contact tracing, and follow-up. The market value includes the value of related goods sold by the service provider or included within the service offering. The monkey pox testing market also includes of sales of serological testing equipment, centrifuges, refrigeration units, biosafety cabinets, automated nucleic acid extractors, and microscopes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Monkey Pox Testing Market Report 2026?

The monkey pox testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the monkey pox testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.